Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Northwest Biotherapeutics
Nieuws
Northwest Biotherapeutics
NWBO
OTC
: NWBO
| ISIN: US66737P6007
2/06/2023
0,610 USD
(-0,02%)
(-0,02%)
2/06/2023
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
21 maart 2023 ·
Northwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. Facility
· Persbericht
12 maart 2023 ·
Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB
· Persbericht
6 januari 2023 ·
Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews 2022 Progress and Looks Forward to Strong 2023
· Persbericht
17 november 2022 ·
Northwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial of DCVax®-L for Glioblastoma
· Persbericht
23 augustus 2022 ·
Northwest Biotherapeutics Announces Approval of Pediatric Investigation Plan (PIP) by MHRA
· Persbericht
6 juli 2022 ·
Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK Facility
· Persbericht
6 juni 2022 ·
Northwest Biotherapeutics Announces Presentations On DCVax®-L Personalized Vaccines, Manufacturing and Scale-Up, and DCVax®-L Clinical Program
· Persbericht
10 mei 2022 ·
Presentation About Phase 3 Trial of DCVax®-L for Glioblastoma Today At New York Academy of Sciences To Be Available Online As Well
· Persbericht
4 mei 2022 ·
Presentation About Phase 3 Trial of DCVax®-L for Glioblastoma To Be Made At New York Academy Of Sciences
· Persbericht
17 februari 2022 ·
Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility
· Persbericht
29 november 2021 ·
Northwest Biotherapeutics Announces $15 Million Financing
· Persbericht
28 oktober 2021 ·
Northwest Biotherapeutics Announces HTA License Issued and MHRA Inspection Conducted for Sawston, UK Facility
· Persbericht
12 mei 2021 ·
UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics (OTCQB: NWBO)
· Persbericht
12 mei 2021 ·
UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics (OTCQB: NWBO)
· Persbericht
16 maart 2021 ·
Northwest Biotherapeutics Announces Development Completed for Initial Production Capacity of Sawston, UK Facility
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe